Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

Arturo Casadevall; D. L. Goldman; M. Feldmesser

doi:10.1016/S0020-2452(97)83532-5

Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

Arturo Casadevall, D. L. Goldman, M. Feldmesser

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

Original language	English (US)
Pages (from-to)	247-257
Number of pages	11
Journal	Bulletin de l'Institut Pasteur
Volume	95
Issue number	4
DOIs	https://doi.org/10.1016/S0020-2452(97)83532-5
State	Published - Jan 1 1997

Keywords

Antibiotic resistance
HIV
Immunoglobulin
Opportunistic infection
RSV
Review
Septic shock
Therapeutics

ASJC Scopus subject areas

Applied Microbiology and Biotechnology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0020-2452(97)83532-5

Cite this

@article{aa61979a21464c2a967eab5e740e0348,

title = "Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?",

abstract = "Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.",

keywords = "Antibiotic resistance, HIV, Immunoglobulin, Opportunistic infection, RSV, Review, Septic shock, Therapeutics",

author = "Arturo Casadevall and Goldman, {D. L.} and M. Feldmesser",

year = "1997",

month = jan,

day = "1",

doi = "10.1016/S0020-2452(97)83532-5",

language = "English (US)",

volume = "95",

pages = "247--257",

journal = "Microbes and Infection",

issn = "1286-4579",

publisher = "Elsevier Masson SAS",

number = "4",

}

TY - JOUR

T1 - Antibody-based therapies for infectious diseases

T2 - Renaissance for an abandoned arsenal?

AU - Casadevall, Arturo

AU - Goldman, D. L.

AU - Feldmesser, M.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

AB - Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

KW - Antibiotic resistance

KW - HIV

KW - Immunoglobulin

KW - Opportunistic infection

KW - RSV

KW - Review

KW - Septic shock

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=0031438485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031438485&partnerID=8YFLogxK

U2 - 10.1016/S0020-2452(97)83532-5

DO - 10.1016/S0020-2452(97)83532-5

M3 - Review article

AN - SCOPUS:0031438485

SN - 1286-4579

VL - 95

SP - 247

EP - 257

JO - Microbes and Infection

JF - Microbes and Infection

IS - 4

ER -

Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this